Lipoprotein (a) is a low-density lipoprotein containing apolipoprotein(a) and identified as a risk factor for atherosclerosis and its related diseases, such as coronary heart disease and stroke. Lipoprotein(a)was discovered in 1963 by Kåre Berg. It is a thrombogenic and atherogenic molecule. Due to lack of data from the north eastern part of the country, a case control study was done with the aim of finding an association and to estimate the serum levels of lipoprotein (a) in patients with Coronary artery disease patients admitted in Intensive Cardiac Care Unit. Lp(a) was quantified by immunoturbidiometric method. The serum lipoprotein (a) levels were significantly elevated (p< 0.0001) in cases (80±30 mg/dl) as compared to controls (30±20 mg//dl). Lipoprotein(a) levels with routine lipid profile testing were assessed. So it is suggested to make LP(a) serum level determination test as a routine laboratory test for identification of risk factor for AMI.

Tapan Debnath was born on 23rd December 1961, he has completed a B.Sc. in Bioscience from Calcutta University in 1980 and earned an MBBS from Manipur University in 1985. After joining the Tripura Government Health Services, he pursued an M.D. in biochemistry, completed in 2002 from the same university. Currently serving as a professor at Tripura Medical College, he has published notable research, including the first Lipoprotein (A) assessment in AMI and CVA patients, which gained attention after publication.